| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,131 | 10,410 | 43,161 | 33,958 | | Cost of Revenue | 6,652 | 8,937 | 33,785 | 32,064 | | | Gross Profit | 1,479 | 1,473 | 9,376 | 1,894 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 454 | 506 | 491 | (2,380) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 984 | 978 | 966 | 961 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 41 | (10) | 7,919 | 3,314 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 55 | 54 | (13) | (79) | | Earnings Before Interest And Taxes | 96 | 44 | 7,906 | 3,235 | | Interest Expense | 1,046 | 1,034 | 1,083 | 1,264 | | Income Before Tax | (950) | (990) | 6,823 | 1,971 | | Income Tax Expense | (387) | (439) | 2,563 | 742 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (563) | (551) | 4,260 | 1,229 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (563) | (551) | 4,260 | 1,229 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($563) | ($551) | $4,260 | $1,229 |
|
0.02% Nasdaq 
Income Statement
